REG - Zotefoams PLC - Notification of Transactions of Directors/PDMRs

ZotefoamsAnnouncement

Today 09:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260415:nRSO5708Aa&default-theme=true

RNS Number : 5708A  Zotefoams PLC  15 April 2026

Zotefoams plc

(the 'Company')

 

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMR

 

15 April 2026

 

The Company has received notification from MUFG Corporate Markets Trustees
(UK) Limited, the Trustee of the Company's Share Incentive Plan (the 'SIP'),
that on 13 April 2026 the following Director and Person Discharging Managerial
Responsibilities became beneficially interested in the number of ordinary
shares of 5 pence each in the Company under the SIP as detailed below.
'Partnership shares' were purchased at a price of £3.7881 per share.

 

The table sets out both the number of partnership shares purchased and the
number of matching shares that were allocated for nil consideration.

 

 Director/PDMR  Number of partnership shares purchased  Number. of matching shares allocated

 R M Cox        40                                      10
 N Wright       40                                      10

 

 

The Notification of Dealing Form can be found below.

 

This announcement is made in accordance with the requirements of Article 19 of
the UK Market Abuse Regulation.

Emma Woollard

Company Secretary

Zotefoams plc

020 8051 2770

 

Enquiries:

 

 Zotefoams plc            IFC Advisory (Financial PR & IR)
 Ronan Cox, Group CEO     Graham Herring

 Nick Wright, Group CFO   Tim Metcalfe

                          Zach Cohen

 +44 (0) 208 664 1600     +44 (0) 203 934 6630

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in high-performance foam
technology delivering optimal material solutions for the benefit of society.
Utilising a variety of unique manufacturing processes, including
environmentally friendly nitrogen expansion for lightweight
AZOTE(®) polyolefin and ZOTEK(®) high-performance foams, Zotefoams sells
to diverse markets worldwide. Zotefoams uses its own cellular materials to
manufacture T-FIT(®) advanced insulation for demanding industrial markets.

 

Zotefoams is headquartered in London, UK, with manufacturing sites
in Croydon, UK, Kentucky, USA and Brzeg, Poland (foam
manufacture), Oklahoma, USA (foam products manufacture and conversion),
Anglesola and Burgos, Spain (foam manufacture) and Jiangsu
Province, China (T-FIT).

 

www.zotefoams.com (http://www.zotefoams.com/)

 

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks
of Zotefoams plc

 

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY
ASSOCIATED PERSONS

 

 1.  Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name: Ronan Michael Cox
 2.  Reason for the notification
 a)  Position/status: Group CEO
 b)  Initial notification/Amendment: Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name:   Zotefoams plc
 b)  LEI: 213800B6P256B5XN8D32
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument:

     Ordinary shares of 5 pence each

     Identification code: GB0009896605
 b)  Nature of the transaction: Award of matching shares under the Company's Share
     Incentive Plan
 c)  Price(s) and volume(s):

Price(s)  Volume(s)
     £0.00     10
 d)  Aggregated information:

     n/a - single transaction
 e)  Date of the transaction: 13 April 2026
 f)  Place of the transaction: XLON
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument:

     Ordinary shares of 5 pence each

     Identification code: GB0009896605
 b)  Nature of the transaction: Purchase of partnership shares under the Company's
     Share Incentive Plan
 c)  Price(s) and volume(s):

Price(s)  Volume(s)
     £3.7881   40
 d)  Aggregated information:

     n/a - single transaction
 e)  Date of the transaction: 13 April 2026
 f)  Place of the transaction: XLON

d)

Aggregated information:

n/a - single transaction

e)

Date of the transaction: 13 April 2026

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Purchase of partnership shares under the Company's
Share Incentive Plan

c)

Price(s) and volume(s):

 Price(s)  Volume(s)
 £3.7881   40

d)

Aggregated information:

n/a - single transaction

e)

Date of the transaction: 13 April 2026

f)

Place of the transaction: XLON

 

 

 1.  Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name: Nick Wright
 2.  Reason for the notification
 a)  Position/status: Group CFO
 b)  Initial notification/Amendment: Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name:   Zotefoams plc
 b)  LEI: 213800B6P256B5XN8D32
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument:

     Ordinary shares of 5 pence each

     Identification code: GB0009896605
 b)  Nature of the transaction: Award of matching shares under the Company's Share
     Incentive Plan
 c)  Price(s) and volume(s):

Price(s)  Volume(s)
     £0.00     10
 d)  Aggregated information:

     n/a - single transaction
 e)  Date of the transaction: 13 April 2026
 f)  Place of the transaction: XLON
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument:

     Ordinary shares of 5 pence each

     Identification code: GB0009896605
 b)  Nature of the transaction: Purchase of partnership shares under the Company's
     Share Incentive Plan
 c)  Price(s) and volume(s):

Price(s)  Volume(s)
     £3.7881   40
 d)  Aggregated information:

     n/a - single transaction
 e)  Date of the transaction: 13 April 2026
 f)  Place of the transaction: XLON

d)

Aggregated information:

n/a - single transaction

e)

Date of the transaction: 13 April 2026

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Purchase of partnership shares under the Company's
Share Incentive Plan

c)

Price(s) and volume(s):

 Price(s)  Volume(s)
 £3.7881   40

d)

Aggregated information:

n/a - single transaction

e)

Date of the transaction: 13 April 2026

f)

Place of the transaction: XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHIAMPTMTTBMTF



            Copyright 2019 Regulatory News Service, all rights reserved